Collabrx (CLRX) Misses Q2 EPS by 12c

Collabrx (NASDAQ: CLRX) reported Q2 EPS of ($0.61), $0.12 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $64 thousand versus the consensus estimate of $60 thousand.

For earnings history and earnings-related data on Collabrx (CLRX) click here.

You May Also Be Interested In

• Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
• MoonLake Immunotherapeutics (MLTX) Tops Q2 EPS by 9c
• monday.com Ltd. (MNDY) Tops Q2 EPS by 37c; offers guidance